Lifestyle intervention before and during fertility treatment in women with obesity or with overweight and PCOS—a RCT - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Preconception and Ongoing Lifestyle Modifications in Overweight or Obese Women with PCOS Undergoing Fertility Treatment—A Randomized Controlled Trial

  • By

  • Matea Belan

  • Madélie Giguère-Johnson

  • Belina Carranza-Mamane

  • Marie-Hélène Pesant

  • Youssef AinMelk

  • Marie-France Langlois

  • Hélène Lavoie

  • Ellen M Greenblatt

  • Sheila Laredo

  • Margaret Sagle

  • Guy Waddell

  • Farrah Jean-Denis

  • Jean-Patrice Baillargeon

  • December 16, 2025

Share

Objective:

To evaluate the effectiveness of a lifestyle intervention compared with usual care on fertility outcomes in women with obesity and infertility, specifically those with PCOS.

Key Findings:
  • The intervention group lost more weight (−3.21% ± 4.73% vs −0.40% ± 3.66%, P = .003) and waist circumference (−2.62 ± 4.46 cm vs −0.23 ± 3.81 cm, P = .01) at 6 months.
  • Live birth rate was 44.4% in the intervention group vs 35.9% in the control group (RR = 1.24 [95% CI 0.81-1.90]).
  • Clinical pregnancy rates were 52.4% in the intervention group vs 37.5% in the control group (RR = 1.40 [95% CI 0.94-2.07]).
  • Natural pregnancy rates were significantly higher in the intervention group (27.0% vs 12.5%, RR = 2.16 [95% CI 1.01-4.64]).
Interpretation:

While the lifestyle intervention did not significantly increase the live birth rate, it improved natural pregnancy rates, indicating potential benefits in reducing reliance on assisted reproduction.

Limitations:
  • The study excluded women unlikely to conceive naturally, which may limit the generalizability of the findings.
  • The follow-up period was limited to 18 months, which may not capture long-term outcomes.
Conclusion:

A 6-month lifestyle intervention prior to fertility treatments may enhance natural pregnancy rates in overweight or obese women with PCOS, potentially reducing the need for costly assisted reproductive technologies.

Original Source(s)

Related Content